A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Thomas Jefferson University
Thomas Jefferson University
National Institutes of Health Clinical Center (CC)
Ohio State University Comprehensive Cancer Center
National Cancer Institute (NCI)
Janssen Research & Development, LLC
National Cancer Institute (NCI)
Hackensack Meridian Health
University of Nebraska
Acerta Pharma BV
Acerta Pharma BV
Acerta Pharma BV
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
University of Chicago
BeOne Medicines
University of Washington
AstraZeneca
Hoffmann-La Roche
H. Lee Moffitt Cancer Center and Research Institute
Dana-Farber Cancer Institute
BeOne Medicines
Dartmouth-Hitchcock Medical Center
Hutchmed
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Mayo Clinic
Acerta Pharma BV
Acerta Pharma BV
Eli Lilly and Company
Incyte Corporation
National Institutes of Health Clinical Center (CC)
AstraZeneca
Ohio State University Comprehensive Cancer Center
M.D. Anderson Cancer Center
Acerta Pharma BV
H. Lee Moffitt Cancer Center and Research Institute
Fred Hutchinson Cancer Center
City of Hope Medical Center
Mayo Clinic
H. Lee Moffitt Cancer Center and Research Institute
University of California, San Diego
Acerta Pharma BV
H. Lee Moffitt Cancer Center and Research Institute
City of Hope Medical Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
City of Hope Medical Center
Hoffmann-La Roche
University of Washington
Thomas Jefferson University